期刊文献+

左乙拉西坦在儿童癫中的应用 被引量:9

Application of Levetiracetam in Childhood Epilepsy
原文传递
导出
摘要 左乙拉西坦是一种新型抗癫药物,由于其不良反应少、安全性高,已广泛应用于儿童局灶性及全面性癫的治疗。本文对左乙拉西坦在儿童癫及儿童癫综合征中单药及添加使用的疗效及安全性做一综述。 Levetiracetam is a newly well-tolerated antiepileptic agent. It has been used extensively in and geneuralized epilepsy without severe adverse effect. This article reviewed the effect and safety of levetiracetam in child epilepsy and epileptic syndromes as monotherapy or add-on therapy.
作者 肖侠明
出处 《中国临床神经科学》 2011年第1期96-103,共8页 Chinese Journal of Clinical Neurosciences
关键词 左乙拉西坦 儿童癫 癫综合征 levetiracetam child epilepsy epileptic syndrome
  • 相关文献

参考文献61

  • 1No authors listed Proposal for revised classification of epilepsies and epileptic syndromes.Commission on Classification and Terminology of the International League Against Epilepsy.[J].Epilepsia,1989;30:389-399. 被引量:1
  • 2Perucca E.Clinical pharmacology and therapeutic use of the new antiepileptic drugs[J].Fundam Clin Pharmacol,2001,15:405-417. 被引量:1
  • 3Stefan H,Feuerstein TJ.Novel anticonvulsant drugs[J].Pharmacol Ther,2007,113:165-183. 被引量:1
  • 4Lynch BA,Lambeng N,Nocka K,et al.The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam[J].Proc Natl Acad Sci U S A,2004,101:9861-9866. 被引量:1
  • 5Kaminski RM,Matagne A,Leclercq K,et al.SV2A protein is a broad-spectrum anticonvulsant target:functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy[J].Neuropharmacology,2008,54:715-720. 被引量:1
  • 6Lukyanetz,EA,Shkryl VM,Kostyuk PG.Selective blockade of N-type calcium channels by levetiracetam[J].Epilepsia,2002,43:9-18. 被引量:1
  • 7French JA.The role of new antiepileptic drugs[J].Am J Manag Care,2001,7:S209-214. 被引量:1
  • 8Radtke RA.Pharmacokinetics of levetiracetam[J].Epilepsia,2001,42:24-27. 被引量:1
  • 9Patsalos PN.The pharmacokinetic characteristics of levetiracetam[J].Methods Find Exp Clin Pharmacol,2003,25:123-129. 被引量:1
  • 10Patsalos PN.Clinical pharmacokinetics of levetiracetam[J].Clin Pharmacokinet,2004,43:707-724. 被引量:1

二级参考文献44

  • 1王薇薇,吴逊.一种独特的新抗癫痫药——左乙拉西坦[J].临床药物治疗杂志,2004,2(6):52-56. 被引量:3
  • 2田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:43
  • 3Lin HC, Young C, Wang PJ,et al. ACTH therapy for Taiwan Residents chil- dren with West syndrome - efficacy and impact on long - term prognosis [ J ]. Brain Dev.2006.28 ( 3 ) : 196 - 201. 被引量:1
  • 4Callenbach PM, Arts WE, ten Houten R,et al. Add - on levetiracetam in ehildren and adolescents with refractory epilepsy : Results of an open - label muhi - centre study [ J ]. Eur J Paediatr Neurol, 2008,12 (4) : 321 -327. 被引量:1
  • 5Partikian A, Mitchell WG. Major adverse events associated with treatment of infantile spasms [ J ]. J Child Neurol, 2007,22 ( 12 ) : 1360 - 1366. 被引量:1
  • 6Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein [ J ]. Eur J Pharmacol, 2006,536( 1 - 2 ) : 102 - 108. 被引量:1
  • 7Otoul C, de Smedt H, Stockis A. l.ack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy [ J ]. Epilepsia, 2007,48 ( 11 ) : 2111-2115. 被引量:1
  • 8Heo K, Lee BI, Yi SD,et al. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open - label singleann trial in Korean patients[ J]. Seizure,2007,16 (5): 402 - 409. 被引量:1
  • 9Grosso S, Cordelli DM, Franzoni E,et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy [ J]. Seizure,2007,16 ( 4 ) : 345 - 350. 被引量:1
  • 10Lagae L, Buyse G, Deconinck A,et al. Effect of levetiracetam in refractory childhood epilepsy syndromes [ J ]. Eur J Paediatr Neurol, 2003,7 (3) :123 - 128. 被引量:1

共引文献36

同被引文献69

  • 1田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:43
  • 2李劲梅,王学峰,肖飞,曾艳,林涛,席志芹.自身对照左乙拉西坦添加治疗耐药性癫痫部分性发作的疗效及安全性[J].中国新药与临床杂志,2007,26(5):381-384. 被引量:12
  • 3卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701. 被引量:357
  • 4Sahaya K, Goyal MK, Sarwal A, et al. Levetiracetam-induced thrombocytopenia among inpatients : a retrospective study [ J ]. Epilepsia, 2010, 51 (12) : 2492-2495. 被引量:1
  • 5Hartmann H, Schumacher U, Seeck M. Worsening of an immune thrombocytopenia during monotherapy with levetiracetam [ J ]. Aktuelle Neurologie, 2002, 29(9) : 467-468. 被引量:1
  • 6Trakarnpan 17, Bergen D. Levetiracetern induced thrombocytopenia[ EB/OL]. (2008-12-08) [ 2011-11-01 ]. http://www. aesnet, org-USA. 被引量:1
  • 7Meschede A, Runge U, Sabolek M. Thrombocytopenia during levetiracetam therapy[ J ]. Epilepsy Res, 2008, 80 (1) : 91-92. 被引量:1
  • 8Kimland E, Hojeberg B, yon Euler M. Levetiracetam-induced thrombocytopenia[ J ]. Epilepsia, 2004, 45 (7) : 877-878. 被引量:1
  • 9Oghlakian R, Nock C ,Koubeissi M. A case of levetiracetam-induced thrombocytopenia [ J ]. Epileptic Disord, 2010, 12 (4) : 335 -337. 被引量:1
  • 10Peer Mohamed B, Prabhakar P. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child [ J ]. Neuropediatrics, 2009, 40 ( 5 ) : 243-244. 被引量:1

引证文献9

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部